Key Takeaways

  • David Sacks regrets selling Palantir stock in the $20s, a move that cost him and his firm immense upside as the company grew.
  • Sacks estimates an early exit from Enphase, selling shares under $1, resulted in a missed $4 billion opportunity had they held on.
  • Taking a board seat can severely restrict an investor's ability to sell public company stock, hindering liquidity and forcing them to watch winners run without participating.
  • The perceived market cap ceiling has shattered; what was once considered a maximum ($100 billion) is now just a mid-point in an era of multi-trillion-dollar companies.

The Billion-Dollar Regrets of Early Exits

Every venture investor dreams of hitting a home run, but the real test often comes after the IPO: when do you sell? David Sacks, co-host of the All-In Podcast and a seasoned private market investor, recounted the painful lessons of selling too early. His examples weren't small misses; they were billion-dollar blunders that offer a sharp reminder to founders holding equity.

“I mean that’s I’m sure you guys share this. It’s one of the most vexing questions,” Sacks admitted to Dan Loeb and Chamath Palihapitiya. He detailed his firm's early investment in Palantir, a company they backed in the private markets. “We were private investors in Palunteer and I think we sold all our stock in the 20s. Huge mistake.” The agony of watching a past winner ascend further, after you’ve cashed out, is a unique kind of founder’s remorse.

The pain wasn't limited to Palantir. Sacks shared an even more staggering miss with Enphase. “We were also early investors in Enphase and we sold some stock on the IPO and then took a tax hit and I think sold it under a dollar and the stock I think had we stayed on would have made $4 billion.” This isn't just about missing a good return; it's about forfeiting a fortune that could redefine a firm's legacy.

The Liquidity Trap of Board Seats

Beyond the psychological battle of holding a winner, Sacks highlighted a practical pitfall for venture investors: the board seat. For Upstart, where his firm led the B round, he noted a critical lesson. “That was one I think we learned not to go on boards anymore because it restricts your ability to be liquid.”

This is a specific, actionable insight for any founder or early investor. Being on a company's board typically means you're privy to material non-public information, which often means you can't trade the stock without running afoul of insider trading rules. This restriction can force you to hold stock long after you might otherwise sell, watching as market dynamics shift or personal liquidity needs arise. It turns a position of influence into a potential golden cage, especially when a company's public stock goes parabolic.

Old Rules Don't Apply: The Shifting Market Ceiling

Part of the problem, Sacks argues, is a dated mental model of market caps. Ten years ago, the idea of a company being worth $100 billion felt like the absolute peak. He recalled the sentiment around early Facebook: “So back in those days, 10 years ago, we thought a hundred billion dollar market cap company was pretty much as big as anything could get. And so Facebook at 50 or whatever, it’s like the upside was to 100.”

But the market has fundamentally changed. “Things are just totally different now. We have multi-trillion dollar companies,” Sacks observed. This shift means that what once looked like an "expensive" or "fully valued" IPO price might now represent just the starting line for a true winner. The psychological barrier of selling when an IPO valuation seems high is now challenged by a new reality where companies can grow to scales previously unimaginable.

What to Do With This

If you're a founder or an early-stage investor with public company equity, challenge your assumptions about market caps. Instead of defining a "fully valued" exit at a few hundred billion, stress-test your thesis against multi-trillion dollar outcomes. Before accepting a board seat, scrutinize the liquidity restrictions in your agreement; understand how it impacts your ability to sell, and if it's a trade-off you're willing to make against potential returns.